Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Gold Miners Will Rush to this New Cost-Saving Tech

(Image via EnviroLeach Technologies Inc.) New technology is emerging as a potential standard to address two market sectors totaling $193 billion, through eco-friendly methods for the hydrometallurgical extraction of precious metals …. Pioneered by EnviroLe...

Trader predicts Assets direction with this forward-looking indicator

Great traders are often the result of dedication to principle, theory, price study, and a solid understanding of Intermarket market dynamics. The one thing that can't be taught, though, is experience behind the screens and with the markets. The longer a trader spends work...

Metals & Miners Prepare For An Early 2020 Liftoff

Over the moderately quiet 2019 Christmas holiday season, while the US and global stock markets continue to push higher, precious metals and miners have begun to move dramatically higher as fear settles into the markets. Our researchers believe this upside move in metals and mi...

Applied Therapeutics Investors Like the ACTION in Phase 2 Galactosemia Study

Applied Therapeutics' shares traded 25% higher today after the company reported positive topline results from its Pivotal Phase 2 ACTION Study of AT-007 for use in the treatment of galactosemia. The firm expects to file for regulatory approval of AT-007 in H2/20. This...

10 Million Americans Applied for Unemployment Benefits. Will Gold Save the Day?

In just two weeks of March, around 10 million Americans applied for unemployment benefits. That’s more than during the Great Recession. What does it imply for the US economy and the gold market? US Labor Market Sinks In the previous edition of the Fundam...

30 Million of Americans Applied for Unemployment Benefit. Should They Buy Gold?

Just like the BoJ last week, the ECB also expanded its monetary policy easing. Meanwhile across the pond, more than 30 million of Americans applied for the unemployment benefit. What does it all means for the gold market? European Central Banks Expands Its Monetary Policy E...

Applied Genetic Tech's Shares Double on 6-Month X-Linked RP Study Results

Shares of Applied Genetic Technologies skyrocketed to a new 52-week high price after the company reported positive six-month data from its ongoing Phase 1/2 clinical study for treatment in X-Linked Retinitis Pigmentosa. The firm stated that the trial data suggests durable and ...

Biopharma Co. Makes Major Headway Toward Clinical Trials for Treatment of Stroke

(CLICK IMAGE TO PLAY VIDEO) Finding an effective method of preventing the possibility of stroke is something that medical science has grappled with for decades. Now, a Vancouver-based clinical stage biopharmaceutical development company looks to be making significa...

Reliq Re-establishes Itself as Community Care Technology Leader ...

Reliq Re-establishes Itself as Community Care Technology Leader Amidst Sweeping Federal Medicare/Medicaid Changes A shift in the industry leads to big new contracts and parabolic stock performance for this small cap. A sweeping new development in what federal...

Unique Value-Added Antiviral Vaccine Technology Platform

(Click to play video.) Founded in 2018 to improve on protein haptenization and leverage previous vaccine development in the field, Vancouver, BC-based BioVaxys Technology Corp . ( CSE.BIOV , OTCQB: BVAX , Forum ) is a clinical stage biotechnology company that...
1 2 3 4 5 6 7 8 9 10 ...